{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:42:42Z","timestamp":1792622562059,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.radonc.2025.110979","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:41:53Z","timestamp":1748918513000},"page":"110979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Salvage brachytherapy for local recurrence of cancer after definitive irradiation: a GEC-ESTRO narrative review"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-3245","authenticated-orcid":false,"given":"J.M.","family":"Hannoun-Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-808X","authenticated-orcid":false,"given":"G.","family":"Eminowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.Gomez","family":"de Iturriaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Smanyk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"L.","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-1327","authenticated-orcid":false,"given":"A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110979_b0005","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.radonc.2025.110979_b0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1158\/1055-9965.EPI-16-1023","article-title":"Trends in radiation therapy among cancer survivors in the United States, 2000-2030","volume":"26","author":"Bryant","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.radonc.2025.110979_b0015","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"2021 forecasting collaborators. burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the global burden of disease study 2021","volume":"403","author":"Gbd","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.110979_b0020","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.radonc.2025.110979_b0025","unstructured":"Health and Healthcare Hystems. 12 new breakthroughs in the fight against cancer. World Economic Forum. Oct 21, 2024. https:\/\/www.weforum.org\/stories\/2024\/10\/cancer-treatment-and-diagnosis-breakthroughs\/. Access on line 13.03.2025."},{"key":"10.1016\/j.radonc.2025.110979_b0030","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and european organisation for Research and treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0035","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2008.03.032","article-title":"Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy","volume":"71","author":"Georg","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0040","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0050","article-title":"Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis","volume":"23(1):31","author":"Cao","year":"2023","journal-title":"BMC Cancer Jan 9"},{"key":"10.1016\/j.radonc.2025.110979_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer: patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.radonc.2025.110979_b0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with cervical cancer - update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.radonc.2025.110979_b0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/IGC.0000000000000678","article-title":"Pelvic exenterations for advanced and recurrent endometrial cancer: clinical outcomes of 40 patients","volume":"26","author":"Schmidt","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.radonc.2025.110979_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/s10397-019-1055-y","article-title":"Pelvic exenteration in gynecologic cancer: complications and oncological outcome","author":"Lago","year":"2019","journal-title":"Gynecol. Surg."},{"key":"10.1016\/j.radonc.2025.110979_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2023.10.016","article-title":"Outcomes and toxicity in re-irradiation of gynecologic cancer: systematic review of the italian association of radiation and clinical oncology (AIRO)","volume":"179","author":"Critelli","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brachy.2019.11.008","article-title":"American Brachytherapy society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers","volume":"19","author":"Sturdza","year":"2020","journal-title":"Brachytherapy Mar-Apr"},{"key":"10.1016\/j.radonc.2025.110979_b0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brachy.2014.01.008","article-title":"Phase II trial of image-based high-dose-rate interstitial brachytherapy for previously irradiated gynecologic cancer","volume":"13","author":"Mart\u00ednez-Monge","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/gyno.1998.4975","article-title":"Treatment of late recurrent vaginal malignancy after initial radiotherapy for Carcinoma of the cervix: an analysis of 73 cases","volume":"69","author":"Xiang-E","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2018.12.022","article-title":"Outcomes after definitive re-irradiation with 3D brachytherapy with or without external beam radiation therapy for vaginal recurrence of endometrial cancer","volume":"152","author":"Ling","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0105","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.brachy.2014.06.005","article-title":"Reirradiation using high-dose-rate brachytherapy in recurrent carcinoma of uterine cervix","volume":"13","author":"Mahantshetty","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.radonc.2025.110979_b0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2013.01.027","article-title":"Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes","volume":"86","author":"Chen","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1748-717X-9-102","article-title":"Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity","volume":"9","author":"Henr\u00edquez","year":"2014","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.radonc.2016.04.032","article-title":"Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure","volume":"119","author":"Wojcieszek","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0135","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110979_b0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.06.027","article-title":"Radiotherapy for recurrent prostate cancer: 2018 recommendations of the australian and New Zealand radiation oncology genito-Urinary group","volume":"129","author":"Lieng","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.5114\/jcb.2016.64441","article-title":"Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy","volume":"8","author":"Buchser","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5114\/jcb.2015.54050","article-title":"Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy","volume":"7","author":"Kumar","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2020.01.023","article-title":"MRI-guided ultrafocal salvage high-dose-rate Brachytherapy for localized radiorecurrent prostate cancer: updated results of 50 patients","volume":"107","author":"van Son","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2019.09.006","article-title":"Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: a comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy","volume":"141","author":"Henr\u00edquez L\u00f3pez","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00066-024-02205-x","article-title":"Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: asystematic review and meta-analysis","volume":"200","author":"Shen","year":"2024","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.radonc.2025.110979_b0170","article-title":"Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis","author":"Creta","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.radonc.2025.110979_b0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2020.06.031","article-title":"Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer","volume":"150","author":"Sch\u00f6nle","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0180","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2021.10.138","article-title":"Salvage low-dose-rate prostate Brachytherapy: clinical outcomes of a phase 2 trial for local recurrence after external beam radiation therapy (NRG Oncology\/RTOG 0526)","volume":"112","author":"Crook","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0185","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.adro.2020.04.022","article-title":"A novel salvage option for local failure in prostate cancer, reirradiation using external beam or stereotactic radiation therapy: systematic review and meta-analysis","volume":"5","author":"Corkum","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0190","doi-asserted-by":"crossref","unstructured":"Jereczek-Fossa BA, Marvaso G, Zaffaroni M, Gugliandolo SG, Zerini D, Corso F, Gandini S, Alongi F, Bossi A, Cornford P, De Bari B, Fonteyne V, Hoskin P, Pieters BR, Tree AC, Arcangeli S, Fuller DB, Franzese C, Hannoun-Levi JM, Janoray G, Kerkmeijer L, Kwok Y, Livi L, Loi M, Miralbell R, Pasquier D, Pinkawa M, Scher N, Scorsetti M, Shelan M, Toledano A, van As N, Vavassori A, Zilli T, Pepa M, Ost P; on the behalf of the European Society for Radiotherapy, Oncology Advisory Committee on Radiation Oncology Practice (ESTRO ACROP). Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus. Cancer Treat Rev. 2021 Jul;98:102206. doi: 10.1016\/j.ctrv.2021.102206. Epub 2021 Apr 20. PMID:33965893.","DOI":"10.1016\/j.ctrv.2021.102206"},{"key":"10.1016\/j.radonc.2025.110979_b0195","doi-asserted-by":"crossref","first-page":"296.e21","DOI":"10.1016\/j.urolonc.2020.11.002","article-title":"Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: a multicenter retrospective study","volume":"39","author":"Marra","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0200","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.radonc.2025.110979_b0205","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG); Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016\/S0140-6736(11)61629-2. Epub 2011 Oct 19. PMID: 22019144; PMCID: PMC3254252.","DOI":"10.1016\/S0140-6736(11)61629-2"},{"key":"10.1016\/j.radonc.2025.110979_b0210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0360-3016(89)90057-6","article-title":"Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up","volume":"17","author":"Fourquet","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0215","doi-asserted-by":"crossref","unstructured":"Smanyk\u00f3 V, M\u00e9sz\u00e1ros N, \u00dajhelyi M, Fr\u00f6hlich G, Stelczer G, Major T, M\u00e1trai Z, Polg\u00e1r C. Second breast-conserving surgery and interstitial brachytherapy vs. salvage mastectomy for the treatment of local recurrences: 5-year results. Brachytherapy. 2019 May-Jun;18(3):411-419. doi: 10.1016\/j.brachy.2019.02.004. Epub 2019 Mar 16. PMID: 30890318.","DOI":"10.1016\/j.brachy.2019.02.004"},{"key":"10.1016\/j.radonc.2025.110979_b0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10549-017-4208-6","article-title":"Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the german experience","volume":"163","author":"Jendrian","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.radonc.2025.110979_b0225","doi-asserted-by":"crossref","unstructured":"Su Y, Guo R, Xue J, Chi Y, Chi W, Wang J, Yang B, Wu J. Increased Mortality with Repeat Lumpectomy Alone After Ipsilateral Breast Tumor Recurrence. Oncologist. 2019 Sep;24(9):e818-e827. doi: 10.1634\/theoncologist.2018-0606. Epub 2019 Mar 6. PMID: 30842240; PMCID: PMC6738311.","DOI":"10.1634\/theoncologist.2018-0606"},{"key":"10.1016\/j.radonc.2025.110979_b0230","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2018.05.032","article-title":"Long-term risks of secondary cancer for various whole and partial breast irradiation techniques","volume":"128","author":"Hoekstra","year":"2018","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0235","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.ijrobp.2023.06.075","article-title":"Second conservative treatment for local recurrence breast cancer: a GEC-ESTRO oncological outcome and prognostic factor analysis","volume":"117","author":"Hannoun-Levi","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0240","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ijrobp.2020.12.029","article-title":"Salvage mastectomy versus second conservative treatment for second ipsilateral breast tumor event: a propensity score-matched cohort analysis of the GEC-ESTRO breast cancer working group database","volume":"110","author":"Hannoun-Levi","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of breast-conserving surgery and 3-dimensional conformal Partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG Oncology\/RTOG 1014 phase 2 clinical trial","volume":"6","author":"Arthur","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0250","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/cancers15030614","article-title":"Salvage perioperative interstitial high-dose-rate interventional radiotherapy (Brachytherapy) for local recurrences of the Chest Wall following mastectomy and previous external irradiation","volume":"15","author":"Soror","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2025.110979_b0255","doi-asserted-by":"crossref","unstructured":"Auoragh A, Strnad V, Ott OJ, Beckmann MW, Fietkau R. Re-irradiation of the chest wall for local breast cancer recurrence: Results of salvage brachytherapy with hyperthermia. Strahlenther Onkol. 2016 Sep;192(9):617-23. English. doi: 10.1007\/s00066-016-1010-z. Epub 2016 Jul 5. PMID: 27381751.","DOI":"10.1007\/s00066-016-1010-z"},{"key":"10.1016\/j.radonc.2025.110979_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(09)70023-3","article-title":"Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data","author":"Michiels","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0265","doi-asserted-by":"crossref","DOI":"10.1007\/s00066-010-2130-5","article-title":"Pattern of failure after helical tomotherapy in head and neck cancer","author":"Farrag","year":"2010","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.radonc.2025.110979_b0270","doi-asserted-by":"crossref","DOI":"10.1002\/jso.2930140303","article-title":"Surgical management of postradiation residual\/recurrent cancer of the base of the tongue","author":"Pradhan","year":"1980","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/S0305-7372(02)00096-8","article-title":"Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review","author":"Kao","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.radonc.2025.110979_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0347(199910)21:7<591::AID-HED1>3.0.CO;2-Y","article-title":"Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes","author":"Mabanta","year":"1999","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.110979_b0285","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.15.0102","article-title":"Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma","author":"Janot","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0290","article-title":"Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy","author":"Kov\u00e1cs","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0295","doi-asserted-by":"crossref","DOI":"10.5301\/tj.5000614","article-title":"Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review","author":"Tagliaferri","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.radonc.2025.110979_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14080853","article-title":"Local control, survival, and toxicity outcomes with high-dose-rate peri-operative interventional radiotherapy (brachytherapy) in head and neck cancers: a systematic review","author":"Bacorro","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.radonc.2025.110979_b0305","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.radonc.2016.08.023","article-title":"Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: results of a phase I\/II reirradiation study","volume":"122","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0310","doi-asserted-by":"crossref","DOI":"10.14639\/0392-100X-suppl.1-44-2024-N2824","article-title":"Interventional radiotherapy (brachytherapy) for re-irradiation of recurrent head and neck malignancies: oncologic outcomes and morbidity","author":"Bussu","year":"2024","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"10.1016\/j.radonc.2025.110979_b0315","doi-asserted-by":"crossref","DOI":"10.1186\/1748-717X-1-27","article-title":"Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy","author":"Pellizzon","year":"2006","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184549","article-title":"Salvage high-dose-rate interventional radiotherapy (brachytherapy) combined with surgery for regionally relapsed head and neck cancers","author":"Soror","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.110979_b0325","first-page":"297","article-title":"Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy","volume":"32","author":"Rudzianskas","year":"2012","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"10.1016\/j.radonc.2025.110979_b0330","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-016-0583-0","article-title":"Second-line treatment of recurrent HNSCC: tumour debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol","author":"Ritter","year":"2016","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.brachy.2014.11.012","article-title":"Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences","author":"Tagliaferri","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0340","doi-asserted-by":"crossref","DOI":"10.5114\/jcb.2018.79399","article-title":"A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery","author":"Rodin","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0345","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0360-3016(01)01637-6","article-title":"Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results","volume":"51","author":"Puthawala","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0350","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00066-014-0809-8","article-title":"Reirradiation for recurrent head and neck cancer with salvage interstitial pulsed-dose-rate brachytherapy: long-term results","volume":"191","author":"Strnad","year":"2015","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.radonc.2025.110979_b0355","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ijrobp.2004.12.078","article-title":"Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer","volume":"62","author":"Hepel","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0360","first-page":"753","article-title":"Percutaneous ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent head and neck carcinomas","volume":"26","author":"Jiang","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.radonc.2025.110979_b0365","article-title":"Safety and efficacy of CT-guided radioactive iodine-125 seed implantation as a salvage treatment for recurrent head and neck cancer after two or more courses of radiotherapy","author":"Li","year":"2023","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0370","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1463-1318.2006.01018.x","article-title":"Surgery for local recurrence of rectal cancer","volume":"8","author":"Heriot","year":"2006","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.radonc.2025.110979_b0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.soc.2024.07.005","article-title":"Management of Recurrent Anal Cancer","volume":"34","author":"Littlejohn","year":"2025","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"10.1016\/j.radonc.2025.110979_b0380","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3748\/wjg.v17.i13.1674","article-title":"Patterns of local recurrence in rectal cancer after a multidisciplinary approach","volume":"17","author":"Enr\u00edquez-Navascu\u00e9s","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.radonc.2025.110979_b0385","doi-asserted-by":"crossref","unstructured":"Colson D, Yalvac B, Weterings J, Verrijssen AS, van Haaren P, Bellezzo M, Berb\u00e9e M, Van Limbergen EJ, Croce O, Verhaegen F, Reniers B. Dosimetry and Monte Carlo modelling of the Papillon+ contact X-ray brachytherapy device. Brachytherapy. 2024 Sep-Oct;23(5):535-548. doi: 10.1016\/j.brachy.2024.06.003. Epub 2024 Jul 4.","DOI":"10.1016\/j.brachy.2024.06.003"},{"key":"10.1016\/j.radonc.2025.110979_b0390","first-page":"15","article-title":"GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer","volume":"33","author":"Stewart","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110979_b0395","doi-asserted-by":"crossref","unstructured":"Steinke J, Jordan C, Rossides S, Minnaar H, Yu J, Franklin A, Rockall T, Dhadda AS, Andrew Hunter I, Mills J, Chadwick E, Silverman R, Folkesson J, Radu C, Myint AS, Stewart AJ. Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost- an International multi-institution analysis. Clin Transl Radiat Oncol. 2023 Jan11;39:100580. doi: 10.1016\/j.ctro.2023.100580. PMID: 36686563; PMCID:PMC9852541.","DOI":"10.1016\/j.ctro.2023.100580"},{"key":"10.1016\/j.radonc.2025.110979_b0400","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5114\/jcb.2024.139049","article-title":"Contact X-ray brachytherapy (CXB) as a salvage treatment for rectal cancer patients who developed local tumor re-growth after watch-and-wait approach","volume":"16","author":"Than","year":"2024","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0405","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.brachy.2012.11.003","article-title":"High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients","volume":"12","author":"Chuong","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110979_b0410","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ijrobp.2021.02.006","article-title":"Intraoperative electron beam radiation therapy (IOERT) versus high-dose-rate intraoperative Brachytherapy (HDR-IORT) in patients with an R1 Resection for locally advanced or locally recurrent rectal cancer","volume":"110","author":"Voogt","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0415","first-page":"41","article-title":"ESTRO\/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer","volume":"17","author":"Calvo","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110979_b0420","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijrobp.2009.10.046","article-title":"Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer","volume":"79","author":"Haddock","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0425","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-9966-28-12","article-title":"The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells","volume":"28","author":"Zhuang","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.radonc.2025.110979_b0430","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00066-024-02271-1","article-title":"Outcome of intraoperative brachytherapy as asalvage treatment for locally recurrent rectal cancer","volume":"201","author":"Stoian","year":"2025","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.radonc.2025.110979_b0435","doi-asserted-by":"crossref","first-page":"S596","DOI":"10.1245\/s10434-015-4545-9","article-title":"Interstitial Brachytherapy for the treatment of locally recurrent anorectal cancer","volume":"22","author":"Bishop","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0440","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jrr\/rraa144","article-title":"The dosimetry evaluation of 3D printing non-coplanar template-assisted CT-guided 125I seed stereotactic ablation brachytherapy for pelvic recurrent rectal cancer after external beam radiotherapy","volume":"62","author":"Wang","year":"2021","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.radonc.2025.110979_b0445","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12032-009-9227-7","article-title":"CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy","volume":"27","author":"Wang","year":"2010","journal-title":"Med. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0450","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2013.03.026","article-title":"GEC-ESTRO breast cancer working group. accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO breast cancer working group","volume":"108","author":"Hannoun-Levi","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110979_b0455","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0360-3016(02)02785-2","article-title":"Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation","volume":"53","author":"Deutsch","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.radonc.2025.110979_b0460","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s00345-024-05205-9","article-title":"Systematic review and recommendations for re-irradiation for intraprostatic radiorecurrent prostate cancer after definitive radiation therapy","volume":"42","author":"Saripalli","year":"2024","journal-title":"World J. Urol."},{"key":"10.1016\/j.radonc.2025.110979_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.brachy.2013.10.008","article-title":"Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma","author":"Strnad","year":"2014","journal-title":"Brachytherapy"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:21:59Z","timestamp":1761128519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025044834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":93,"alternative-id":["S0167814025044834"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110979","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage brachytherapy for local recurrence of cancer after definitive irradiation: a GEC-ESTRO narrative review","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110979"}}